NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Health Information Services · USD

Health Catalyst, Inc. (HCAT) Stock Analysis

Health Catalyst, Inc. (HCAT) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

HCAT

$1.69

−$0.02 (−1.17%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HCAT with… →

HCAT Key Statistics

As of Sep 4, 2026
Trading
Open
$1.68
Previous Close
$1.71
Day's Range
1.67–1.71
52-Week Range
0.96–3.62
Volume
400.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.53
Valuation
Market Cap
$127.18M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
215.29
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.44
EPS (ttm)Profit attributable to each share over the last twelve months.
−3.67
Financials (FY)
Revenue (FY)
$311.14M+1.48%
Net Income (FY)
−$177.97M
Profit marginThe share of revenue left as profit after all costs and taxes.
−90.61%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
75.26M
1-Year Return
−48.79%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
1.14M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HCAT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−29.29%
2025−66.20%
2024−23.65%
2023−12.89%
2022−73.17%
2021−8.98%
2020+25.45%
2019 (partial year)−11.41%

As of September 4, 2026.

HCAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$311.14M−$177.97M−57.2%
2024$306.58M−$69.50M−22.7%
2023$295.94M−$118.15M−39.9%
2022$276.24M−$137.40M−49.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$311.14M$151.68M−$42.74M−$177.97M−57.2%
2024$306.58M$140.78M−$57.61M−$69.50M−22.7%
2023$295.94M$131.83M−$100.00M−$118.15M−39.9%
2022$276.24M$133.19M−$140.01M−$137.40M−49.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HCAT Valuation vs Health Information Services Median

Median of 53 stocks
MetricHCATHealth Information Services medianvs median
P/S ratio0.442.660.2x the median
Profit margin−90.61%0.00%90.6 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 17 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Health Catalyst, Inc. (HCAT) at $127.18M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 1,200 employees.

The 52-week range on file runs from $0.96 to $3.62. The most recent close on file for HCAT is $1.69, dated September 4, 2026. That is −$0.02 (−1.17%) against the previous close. The latest close sits 76.96% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $311.14M. That is +1.48% against the prior fiscal year, when revenue was $306.58M. The same year closed with a net loss of $177.97M. Profit margin runs at −90.61%. That is 90.6 percentage points below the Health Information Services median of 0%. Earnings per share on a trailing basis come to −3.67.

Across the 4 fiscal years on file, revenue moves from $276.24M in 2022 to $311.14M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 215.29. The price-to-sales ratio is 0.44. On price-to-sales that is 0.2 times the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

Over the trailing twelve months the price has returned −48.79%. Measured over 5 years, that is −50.06% a year compounded. The reported beta is 1.53. Daily returns over the trailing 7 years annualize to a volatility of 68.09%.

Growth & Income

The record shows no dividend for HCAT.

The strongest complete calendar year on file is 2020 at +25.45%; the weakest is 2022 at −73.17%. Of the 6 complete calendar years on file, 1 finished higher. So far in 2026 the price is −29.29%.

Peer Comparison

Health Catalyst, Inc. (HCAT) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Health Catalyst, Inc. HCAT $127.18M —
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. Health Catalyst, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Visit website →